Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Non-small cell lung cancer

  • You have access
    Lymph Node Metastasis Location and Postoperative Adjuvant Chemotherapy in Patients With pN1 Stage IIB Non-small Cell Lung Cancer
    RYUICHI ITO, TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, TAKUYA KIMURA, KAZUYA KISHIMOTO and NORITOSHI NISHIYAMA
    In Vivo January 2022, 36 (1) 355-360; DOI: https://doi.org/10.21873/invivo.12710
  • You have access
    Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
    HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE and JIN WOO KIM
    In Vivo November 2021, 35 (6) 3423-3430; DOI: https://doi.org/10.21873/invivo.12642
  • You have access
    Induction of Apoptosis and Inhibition of EGFR/NF-κB Signaling Are Associated With Regorafenib-sensitized Non-small Cell Lung Cancer to Cisplatin
    JENG-YUAN WU, YUEH-SHAN WENG, YI-CHOU CHIOU, FEI-TING HSU and I-TSANG CHIANG
    In Vivo September 2021, 35 (5) 2569-2576; DOI: https://doi.org/10.21873/invivo.12539
  • You have access
    Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm
    MOTOAKI YASUKAWA, TAKESHI KAWAGUCHI, MICHITAKA KIMURA, TAKASHI TOJO and SHIGEKI TANIGUCHI
    In Vivo March 2021, 35 (2) 1027-1031; DOI: https://doi.org/10.21873/invivo.12346
  • You have access
    An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
    CARSTEN NIEDER and KRISTIAN S. IMINGEN
    In Vivo March 2021, 35 (2) 955-958; DOI: https://doi.org/10.21873/invivo.12336
  • You have access
    Weak-evidence Fusion Candidates Detected by a FusionPlex Assay Using the Ion Torrent System
    SHIRO FUJITA, KATSUHIRO MASAGO, EIICHI SASAKI, SATOSHI TSUKUSHI, YOSHITSUGU HORIO, HIROAKI KURODA and TOYOAKI HIDA
    In Vivo March 2021, 35 (2) 993-998; DOI: https://doi.org/10.21873/invivo.12342
  • You have access
    Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors
    JACLYN LOPICCOLO, SHIGERU KAWABATA, JOELL J. GILLS and PHILLIP A. DENNIS
    In Vivo January 2021, 35 (1) 141-145; DOI: https://doi.org/10.21873/invivo.12241
  • You have access
    Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer
    MASATOSHI NAKAMURA, KAYOKO OHNISHI, HITOSHI ISHIKAWA, KENSUKE NAKAZAWA, TOSHIHIRO SHIOZAWA, TOSHIYUKI OKUMURA, IKUO SEKINE, YUKIO SATO, NOBUYUKI HIZAWA and HIDEYUKI SAKURAI
    In Vivo July 2020, 34 (4) 1883-1892; DOI: https://doi.org/10.21873/invivo.11984
  • You have access
    Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients
    KUNIHIKO MIYAZAKI, SHINYA SATO, TAKAHIDE KODAMA, TAKESHI NUMATA, TAKEO ENDO, YUSUKE YAMAMOTO, KEI SHIMIZU, HIDEYASU YAMADA, KENJI HAYASHIHARA, SHINICHIRO OKAUCHI, HIROAKI SATOH, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUTO SAITO, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, HIROKO WATANABE, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, YASUNORI FUNAYAMA, SHIGEN HAYASHI, HIROYUKI NAKAMURA and TAKAAKI YAMASHITA
    In Vivo July 2020, 34 (4) 2001-2007; DOI: https://doi.org/10.21873/invivo.11998
  • You have access
    High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data
    MARIACARMELA SANTARPIA, GIUSEPPE ALTAVILLA, NICOLO BORSELLINO, ANDREA GIRLANDO, GIANFRANCO MANCUSO, STEFANO PERGOLIZZI, DARIO PIAZZA, ANTONIO PONTORIERO, MARIA ROSARIA VALERIO and VITTORIO GEBBIA
    In Vivo July 2020, 34 (4) 2009-2014; DOI: https://doi.org/10.21873/invivo.11999

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
In Vivo

© 2026 In Vivo

Powered by HighWire